Deerfield Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,049,035
| Closed | -$18.3M | – | 165 |
|
|
2020
Q4 | $18.3M | Buy |
1,049,035
+420,896
| +67% | +$5.9M | 0.36% | 75 |
|
|
2020
Q3 | $7.35M | Sell |
628,139
-216,861
| -26% | -$2.88M | 0.18% | 91 |
|
|
2020
Q2 | $11M | Buy |
845,000
+690,604
| +447% | +$8.3M | 0.32% | 75 |
|
|
2020
Q1 | $1.43M | Buy |
+154,396
| New | +$2.16M | 0.05% | 85 |
|
|
2018
Q4 | – | Sell |
-1,087,359
| Closed | -$17.6M | – | 112 |
|
|
2018
Q3 | $17.6M | Sell |
1,087,359
-223,641
| -17% | -$3.2M | 0.63% | 51 |
|
|
2018
Q2 | $16.9M | Sell |
1,311,000
-133,000
| -9% | -$1.8M | 0.59% | 63 |
|
|
2018
Q1 | $18M | Buy |
1,444,000
+180,000
| +14% | +$2.19M | 0.62% | 59 |
|
|
2017
Q4 | $17.7M | Buy |
1,264,000
+318,290
| +34% | +$4.66M | 0.7% | 45 |
|
|
2017
Q3 | $15.9M | Hold |
945,710
| – | – | 0.72% | 45 |
|
|
2017
Q2 | $15.9M | Buy |
945,710
+329,202
| +53% | +$4.92M | 0.85% | 35 |
|
|
2017
Q1 | $9.55M | Buy |
616,508
+87,311
| +16% | +$1.25M | 0.37% | 70 |
|
|
2016
Q4 | $7.91M | Buy |
529,197
+64,656
| +14% | +$908K | 0.33% | 66 |
|
|
2016
Q3 | $5.83M | Hold |
464,541
| – | – | 0.27% | 57 |
|
|
2016
Q2 | $4.18M | Hold |
464,541
| – | – | 0.16% | 78 |
|
|
2016
Q1 | $4.6M | Sell |
464,541
-55,129
| -11% | -$565K | 0.2% | 74 |
|
|
2015
Q4 | $5.98M | Hold |
519,670
| – | – | 0.24% | 75 |
|
|
2015
Q3 | $7.02M | Sell |
519,670
-41,556
| -7% | -$563K | 0.27% | 78 |
|
|
2015
Q2 | $7.77M | Buy |
561,226
+38,976
| +7% | +$527K | 0.26% | 80 |
|
|
2015
Q1 | $7.35M | Buy |
+522,250
| New | +$7.11M | 0.24% | 73 |
|
Deerfield Management's OXFD Position: Q1 2021 in Review
Deerfield Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 1,049,035 shares — an estimated $18.3M sold.
Deerfield Management first reported a position in OXFD in Q1 2015 and held it in 19 quarters. The position peaked at $18.3M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Deerfield Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Deerfield Management sold 1,049,035 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $18.3M.
- Deerfield Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2015 and held it in 19 quarters.
- Deerfield Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $18.3M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Deerfield Management's 13F filing for Q1 2021, filed 17 May 2021.